Signs you're ready to move to the next dose: GI symptoms (nausea, vomiting, diarrhea) have resolved or are minimal for at least 7 consecutive days Appetite suppression remains noticeable but you sense a plateau effect developing at the current dose You have completed at least 4 full weeks at the current dose level You have no significant intercurrent illness that might confuse attribution of new symptoms Signs to wait: Ongoing nausea or vomiting, even if mild, at the end of the current dose phase A recent GI illness (unrelated to the medication) that makes it hard to attribute current symptoms A major life stressor or schedule disruption that might amplify side effects Fewer than 4 weeks at the current dose, regardless of how you feel When in doubt, an additional week at the current dose costs very little
Meaningful visible changes to firmness and fine lines: 4-8 weeks
The COA should test for Dihexa specifically (correct mass, correct CAS), not a generic "peptide" assay
INTRODUCTION TO INSULIN-LIKE GROWTH FACTOR (IGF-1) Insulin-like growth factor (IGF-1) is a protein hormone produced mainly in the liver that plays a key role in cell growth and development
The company stands out in the prescription refill category for two reasons: it exclusively uses board-certified physicians rather than nurse practitioners or physician assistants, and it accepts over 100 insurance plans, including Aetna, Cigna, UnitedHealthcare, Anthem, and Humana
